Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults
一项在健康泰国成年人中进行的开放标签随机研究,旨在评估异源性基础免疫接种(包括CoronaVac、ChAdox1 nCov-19和BNT162b2疫苗)以及BNT162b2加强免疫接种对SARS-CoV-2变异株的免疫原性和反应原性。
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2022.2091865
Niyomnaitham, Suvimol; Quan Toh, Zheng; Wongprompitak, Patimaporn; Jansarikit, Laddawan; Srisutthisamphan, Kanjana; Sapsutthipas, Sompong; Jantraphakorn, Yuparat; Mingngamsup, Natthakarn; Licciardi, Paul V; Chokephaibulkit, Kulkanya